Medicine Experts

Eli Frydman

Chairman of the Board


  With 17 years diverse industry experience, Dr. Frydman is currently Managing Director – Healthcare for Aurum Ventures MKI. Prior to his current position, he served as the Chief Business Officer of FutuRx, the drug development incubator established by J&J, Orbimed and Takeda. Prior to that, Eli served for 10 years as the COO of Aposense Ltd., a drug development and molecular imaging company (TASE: APOS), with responsibilities for business development, operations and finance. Before joining Aposense, he served as a Senior Business Development manager at GE Healthcare Europe (based in France), doing healthcare M&A across Europe. Eli holds an MBA from the Ecole des Ponts, Paris, and a PhD in Chemistry (nanotechnology) from the Weizmann Institute of Science.  

Research Interest

Pharmaceutical science 

Global Experts from Israel

Global Experts in Subject

Share This Profile